Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Change in prostate volume measured in cm^3

Outcome Description:

Change in prostate volume measured with trans-rectal ultrasound at baseline versus prostate volume measured with KVCT and MVCT.

Outcome Time Frame:

One month post implant

Safety Issue:

No

Principal Investigator

William St. Clair, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Lucille P. Markey Cancer Center at University of Kentucky

Authority:

United States: Food and Drug Administration

Study ID:

13-RAD-01

NCT ID:

NCT01810627

Start Date:

March 2013

Completion Date:

April 2015

Related Keywords:

• Prostate Cancer
• Prostate
• Cancer
• Prostatic Neoplasms

Name	Location
Markey Cancer Center	Lexington, Kentucky  40536